321 related articles for article (PubMed ID: 35163960)
21. Carotenoids and Carotenoid Esters of Red and Yellow Physalis (Physalis alkekengi L. and P. pubescens L.) Fruits and Calyces.
Wen X; Hempel J; Schweiggert RM; Ni Y; Carle R
J Agric Food Chem; 2017 Aug; 65(30):6140-6151. PubMed ID: 28696106
[TBL] [Abstract][Full Text] [Related]
22. Systems pharmacology reveals the mechanism of activity of Physalis alkekengi L. var. franchetii against lipopolysaccharide-induced acute lung injury.
Yang Y; Ding Z; Wang Y; Zhong R; Feng Y; Xia T; Xie Y; Yang B; Sun X; Shu Z
J Cell Mol Med; 2020 May; 24(9):5039-5056. PubMed ID: 32220053
[TBL] [Abstract][Full Text] [Related]
23. Two new physalin derivatives from
Sun JL; Jiang YJ; Cheng L
Nat Prod Res; 2021 Jan; 35(2):203-206. PubMed ID: 31140313
[TBL] [Abstract][Full Text] [Related]
24. The alleviative effect of flavonol-type Nrf2 activator rhamnazin from Physalis alkekengi L. var. franchetii (Mast.) Makino on pulmonary disorders.
Wu XY; Wang T; Hu HX; Zhang K; Zhao Y; Zhao BB; Lou HX; Wang XN; Shen T
Phytother Res; 2022 Apr; 36(4):1692-1707. PubMed ID: 35129872
[TBL] [Abstract][Full Text] [Related]
25. Quantitative and transformation product analysis of major active physalins from Physalis alkekengi var. franchetii (Chinese lantern) using ultraperformance liquid chromatography with electrospray ionisation tandem mass spectrometry and time-of-flight mass spectrometry.
Zheng Y; Chen Y; Ren Y; Luan L; Wu Y
Phytochem Anal; 2012; 23(4):337-44. PubMed ID: 21997776
[TBL] [Abstract][Full Text] [Related]
26. Identification of absorbed constituents and in vivo metabolites in rats after oral administration of Physalis alkekengi var. franchetii by ultra-high-pressure liquid chromatography quadrupole time-of-flight mass spectrometry.
Feng X; Huo X; Liu H; Chai L; Ding L; Qiu F
Biomed Chromatogr; 2018 Mar; 32(3):. PubMed ID: 29055030
[TBL] [Abstract][Full Text] [Related]
27. Two new sesquiterpenoid glycoside compounds from the calyces of
Teng Y; Zhang XR; Li XL; Gao J; Ni L; Zhan GQ
J Asian Nat Prod Res; 2024 Jul; 26(7):795-802. PubMed ID: 38515328
[TBL] [Abstract][Full Text] [Related]
28.
Fu Y; Zhu F; Ma Z; Lv B; Wang X; Dai C; Ma X; Liu P; Lv H; Chen X; Chen Z; Shen L
Onco Targets Ther; 2021; 14():301-314. PubMed ID: 33469308
[TBL] [Abstract][Full Text] [Related]
29. Isolation and characterization of cytotoxic withanolides from the calyx of Physalis alkekengi L. var franchetii.
Sun Y; Guo T; Zhang FB; Wang YN; Liu Z; Guo S; Li L
Bioorg Chem; 2020 Mar; 96():103614. PubMed ID: 32007725
[TBL] [Abstract][Full Text] [Related]
30. Six new physalins from Physalis alkekengi var. franchetii and their cytotoxicity and antibacterial activity.
Yang YK; Xie SD; Xu WX; Nian Y; Liu XL; Peng XR; Ding ZT; Qiu MH
Fitoterapia; 2016 Jul; 112():144-52. PubMed ID: 27215128
[TBL] [Abstract][Full Text] [Related]
31. Antimicrobial activity of the extracts and physalin D from Physalis alkekengi and evaluation of antioxidant potential of physalin D.
Helvaci S; Kökdil G; Kawai M; Duran N; Duran G; Güvenç A
Pharm Biol; 2010 Feb; 48(2):142-50. PubMed ID: 20645830
[TBL] [Abstract][Full Text] [Related]
32. New sesquiterpenoids with COX-2 inhibitory activity from the medical plant Physalis. alkekengi L. var. franchetii.
Zhang JL; Zhou FF; Li YZ; Feng T; Jiang LL; Jiang RW; Zhang XX; Li XD
Fitoterapia; 2020 Mar; 141():104470. PubMed ID: 31917300
[TBL] [Abstract][Full Text] [Related]
33. Metabolite Profiling, through LC-ESI/LTQOrbitrap/MS Analysis, of Antioxidant Extracts from
Crescenzi MA; Serreli G; Deiana M; Tuberoso CIG; Montoro P; Piacente S
Antioxidants (Basel); 2023 Dec; 12(12):. PubMed ID: 38136220
[TBL] [Abstract][Full Text] [Related]
34. LC-MS/MS method for simultaneous determination of flavonoids and physalins in rat plasma: Application to pharmacokinetic study after oral administration of Physalis alkekengi var. franchetii (Chinese lantern) extract.
Guo Y; Liu H; Ding L; Oppong M; Pan G; Qiu F
Biomed Chromatogr; 2017 Oct; 31(10):. PubMed ID: 28273367
[TBL] [Abstract][Full Text] [Related]
35. Steroids and flavonoids from Physalis alkekengi var. franchetii and their inhibitory effects on nitric oxide production.
Qiu L; Zhao F; Jiang ZH; Chen LX; Zhao Q; Liu HX; Yao XS; Qiu F
J Nat Prod; 2008 Apr; 71(4):642-6. PubMed ID: 18348534
[TBL] [Abstract][Full Text] [Related]
36. Two new 3-hexenol glycosides from the calyces of
Shu Z; Tang Y; Yang Y; Ding Z; Zhong R; Xia T; Li X; Zheng C; Wen Z; Li W; Wang Y
Nat Prod Res; 2021 Apr; 35(8):1274-1280. PubMed ID: 31343265
[TBL] [Abstract][Full Text] [Related]
37. First Report of Powdery Mildew Caused by Golovinomyces magnicellulatus var. magnicellulatus on Physalis alkekengi var. franchetii in China.
Liang C; Xing HH; Liu Z; Cho SE; Shin HD
Plant Dis; 2013 Oct; 97(10):1382. PubMed ID: 30722154
[TBL] [Abstract][Full Text] [Related]
38. A pair of 3-epimeric physalins from Physalis alkekengi L. var. franchetii.
Qiu L; Jiang ZH; Liu HX; Chen LX; Yao XS; Qiu F
J Asian Nat Prod Res; 2008; 10(9-10):881-5. PubMed ID: 18985501
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of in vitro/in vivo anti-diabetic effects and identification of compounds from Physalis alkekengi.
Hu XF; Zhang Q; Zhang PP; Sun LJ; Liang JC; Morris-Natschke SL; Chen Y; Lee KH
Fitoterapia; 2018 Jun; 127():129-137. PubMed ID: 29447981
[TBL] [Abstract][Full Text] [Related]
40. Chromatographic analysis of carotenol fatty acid esters in Physalis alkekengi and Hippophae rhamnoides.
Pintea A; Varga A; Stepnowski P; Socaciu C; Culea M; Diehl HA
Phytochem Anal; 2005; 16(3):188-95. PubMed ID: 15997852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
